The Effects of Temporary Tube Ligation in Ahmed Glaucoma Valve Surgery

What this Trial Is About

Researchers are studying patients with glaucoma who need surgery using the Ahmed FP7 glaucoma valve implant. The study aims to compare two surgical techniques to see if delaying early fluid flow through the Ahmed tube shunt improves post-operative results and reduces complications. This randomized, prospective, multi-center study takes place at several U.S. institutions and focuses on whether limiting early fluid flow reduces inflammation, scarring, and improves long-term eye pressure control. Participants will be randomly assigned to one of two groups: one receiving the standard Ahmed valve implantation without a ligature, and the other receiving implantation with a vicryl ligature to delay early flow through the tube. The study will observe differences in surgical outcomes between these two approaches. The use of the ligature is intended to reduce early fluid flow and potentially improve healing and reduce complications like the hypertensive phase or hypotony. During the study, eye pressure levels will be measured at day one, week one, and at months one, three, six, and twelve after surgery. Researchers will also track the number of glaucoma medications used and any post-operative complications. The main goal is to evaluate changes in intraocular pressure over a year and assess medication adjustments and complication rates. Participation involves regular follow-ups to monitor eye health and surgical outcomes over 12 months.

Tied Tube Trial in Glaucoma Surgery